Published in Ann N Y Acad Sci on June 11, 1971
Con--mutants: class of mutants in Escherichia coli K-12 lacking a major cell wall protein and defective in conjugation and adsorption of a bacteriophage. J Bacteriol (1974) 4.63
F + , Hfr, and F' strains of Salmonella typhimurium and Salmonella abony. Bacteriol Rev (1972) 3.73
Escherichia coli females defective in conjugation and in adsorption of a single-stranded deoxyribonucleic acid phage. J Bacteriol (1974) 1.20
Influence of lipopolysaccharide and protein in the cell envelope on recipient capacity in conjugation of Salmonella typhimurium. J Bacteriol (1981) 1.08
Behavior of a hybrid F' ts114 lac+, his+ factor (F42-400) in Klebsiella pneumoniae M5a1. J Bacteriol (1975) 0.81
T2 lipopolysaccharide antigen of Salmonella: genetic determination of T2 and properties of the T2, T2,S, and T2,SR Forms. Infect Immun (1976) 0.80
OX VITREOUS HUMOUR. 1.-THE RESIDUAL PROTEIN. Br J Ophthalmol (1948) 7.46
THE SYNTHESIS OF A POLYSACCHARIDE FROM GLUCOSE-1-PHOSPHATE IN MUSCLE EXTRACT. Science (1939) 7.02
Evolution of plasmid-coded resistance to broad-spectrum cephalosporins. Antimicrob Agents Chemother (1985) 5.74
Bacterial endotoxin: molecular relationships of structure to activity and function. FASEB J (1994) 5.70
Chromosomal beta-lactamases of Enterobacter cloacae are responsible for resistance to third-generation cephalosporins. Antimicrob Agents Chemother (1983) 5.16
Cloning and characterization of genes involved in production of mannose-resistant, neuraminidase-susceptible (X) fimbriae from a uropathogenic O6:K15:H31 Escherichia coli strain. Infect Immun (1985) 3.58
Structural relationship of Salmonella O and R antigens. Ann N Y Acad Sci (1966) 3.54
Intestinal colonization and virulence of Salmonella in mice. Infect Immun (1978) 3.44
Immunochemistry of R lipopolysaccharides of Escherichia coli. Different core regions in the lipopolysaccharides of O group 8. Eur J Biochem (1969) 2.89
The N-terminal domain of Pseudomonas aeruginosa exoenzyme S is a GTPase-activating protein for Rho GTPases. J Biol Chem (1999) 2.78
Activities, events and outcomes in ambulatory patient care. N Engl J Med (1969) 2.63
The negative regulator of beta-lactamase induction AmpD is a N-acetyl-anhydromuramyl-L-alanine amidase. FEMS Microbiol Lett (1994) 2.60
GAP activity of the Yersinia YopE cytotoxin specifically targets the Rho pathway: a mechanism for disruption of actin microfilament structure. Mol Microbiol (2000) 2.56
Immunochemical studies on core lipopolysaccharides of Enterobacteriaceae of different genera. Eur J Biochem (1970) 2.29
Deamidation of Cdc42 and Rac by Escherichia coli cytotoxic necrotizing factor 1: activation of c-Jun N-terminal kinase in HeLa cells. Infect Immun (1999) 2.26
Immunochemistry of R lipopolysaccharides of Escherichia coli. Studies on R mutants with an incomplete core, derived from E. coli O8:K27. Eur J Biochem (1970) 2.18
Amikacin resistance mediated by multiresistance transposon Tn2424. J Bacteriol (1983) 2.15
Escherichia coli adhesion to Saccharomyces cerevisiae and mammalian cells: role of piliation and surface hydrophobicity. Infect Immun (1981) 2.09
Chemistry and biology of the enterobacterial common antigen (ECA). Curr Top Microbiol Immunol (1979) 1.99
Impact of gyrA and parC mutations on quinolone resistance, doubling time, and supercoiling degree of Escherichia coli. Antimicrob Agents Chemother (1999) 1.99
The paradox of low body mass index and high body fat percentage among Chinese, Malays and Indians in Singapore. Int J Obes Relat Metab Disord (2000) 1.99
Concordant genotype of upper and lower airways P aeruginosa and S aureus isolates in cystic fibrosis. Thorax (2009) 1.90
Development of resistance to nalidixic acid and the fluoroquinolones after the introduction of norfloxacin and ofloxacin. Antimicrob Agents Chemother (1988) 1.88
The signal molecule for beta-lactamase induction in Enterobacter cloacae is the anhydromuramyl-pentapeptide. Antimicrob Agents Chemother (1997) 1.84
Characterization of pili associated with Escherichia coli O18ac. Infect Immun (1980) 1.80
Pseudomonas aeruginosa ExoT is a Rho GTPase-activating protein. Infect Immun (2000) 1.78
In vitro activities of ertapenem (MK-0826) against recent clinical bacteria collected in Europe and Australia. Antimicrob Agents Chemother (2001) 1.74
Pseudomonas aeruginosa exoenzyme S ADP-ribosylates Ras at multiple sites. J Biol Chem (1998) 1.73
Insertions of resistance genes into Tn21-like transposons. J Antimicrob Chemother (1986) 1.70
The chemical structure of bacterial endotoxin in relation to bioactivity. Immunobiology (1993) 1.69
Interaction of small dermatan sulfate proteoglycan from fibroblasts with fibronectin. J Cell Biol (1987) 1.68
Rho GTPases as targets of bacterial protein toxins. Biol Chem (2000) 1.68
Effects of Escherichia coli hemolysin on human monocytes. Cytocidal action and stimulation of interleukin 1 release. J Clin Invest (1990) 1.64
Resistance mechanisms of multiresistant Pseudomonas aeruginosa strains from Germany and correlation with hypermutation. Antimicrob Agents Chemother (2007) 1.63
From registry to quality management: the German Cystic Fibrosis Quality Assessment project 1995 2006. Eur Respir J (2007) 1.61
HR 810, a cephalosporin with low affinity for Enterobacter cloacae beta-lactamase. Eur J Clin Microbiol (1983) 1.59
Molecular nature of a streptomycin and sulfonamide resistance plasmid (pBP1) prevalent in clinical Escherichia coli strains and integration of an ampicillin resistance transposon (TnA). Antimicrob Agents Chemother (1981) 1.58
On a bacteriophage T3 and T4 receptor region within the cell wall lipopolysaccharide of Escherichia coli B. J Mol Biol (1976) 1.57
Characterization of Tn2411 and Tn2410, two transposons derived from R-plasmid R1767 and related to Tn2603 and Tn21. J Bacteriol (1983) 1.57
Application of the Woman Abuse Screening Tool (WAST) and WAST-short in the family practice setting. J Fam Pract (2000) 1.56
Value of programmed ventricular stimulation for prophylactic internal cardioverter-defibrillator implantation in postinfarction patients preselected by noninvasive risk stratifiers. J Am Coll Cardiol (2001) 1.55
Small-angle neutron scattering study of lateral phase separation in dimyristoylphosphatidylcholine-cholesterol mixed membranes. Biochemistry (1985) 1.51
[Stability of coli flora of the healthy human. 1. The occurrence of permanent and changing types]. Arch Hyg Bakteriol (1969) 1.49
Bacterial protein toxins targeting rho GTPases. FEMS Microbiol Lett (2000) 1.46
Tunneling anisotropic magnetoresistance: a spin-valve-like tunnel magnetoresistance using a single magnetic layer. Phys Rev Lett (2004) 1.45
Use of a broad-host-range gyrA plasmid for genetic characterization of fluoroquinolone-resistant gram-negative bacteria. Antimicrob Agents Chemother (1991) 1.42
[Hemagglutinins against a common enterobacteriaceae antigen in E. coli R1-antisera]. Zentralbl Bakteriol Orig (1971) 1.42
Effect of medial displacement calcaneal osteotomy on ankle kinematics in a cadaver model. Foot Ankle Int (1998) 1.39
THE EFFECT OF NUCLEOPHOSPHATASE ON "NATIVE" AND DEPOLYMERIZED THYMONUCLEIC ACID. Science (1938) 1.39
Micrometastatic cancer cells in bone marrow: in vitro detection with anti-cytokeratin and in vivo labeling with anti-17-1A monoclonal antibodies. Proc Natl Acad Sci U S A (1987) 1.36
The impact of body build on the relationship between body mass index and percent body fat. Int J Obes Relat Metab Disord (1999) 1.35
Immunogenicity of the common enterobacterial antigen produced by smooth and rough strains. Infect Immun (1972) 1.35
Sequences of wild-type and mutant ampD genes of Citrobacter freundii and Enterobacter cloacae. Antimicrob Agents Chemother (1993) 1.34
Interleukin-3 is a differentiation factor for human basophils. Blood (1989) 1.34
Genetic transfer of Salmonella O antigens to Escherichia coli O8. J Gen Microbiol (1976) 1.33
Prospective evaluation of emerging bacteria in cystic fibrosis. J Cyst Fibros (2005) 1.33
Beta-lactam antibiotics and selection of resistance: speculation on the evolution of R-plasmids. J Antimicrob Chemother (1986) 1.32
Presence of rfe genes in Escherichia coli: their participation in biosynthesis of O antigen and enterobacterial common antigen. J Bacteriol (1976) 1.32
SOME OBSERVATIONS ON THE EFFECT OF INJECTED CYTOCHROME C IN ANIMALS. J Clin Invest (1945) 1.31
Alternative pathway for the activation of complement in human serum. Formation and composition of the complex with cobra venom factor that cleaves the third component of complement. Hoppe Seylers Z Physiol Chem (1974) 1.29
Isolation, crystallization, crystal structure analysis and refinement of B-phycoerythrin from the red alga Porphyridium sordidum at 2.2 A resolution. J Mol Biol (1992) 1.26
[Investigations on the classification of salmonella R forms. 3. Classification of S. minnesota mutants by chemical agents]. Zentralbl Bakteriol Orig (1969) 1.25
Genetical studies on the lipopolysaccharide structure of Escherichia coli K12. J Gen Microbiol (1973) 1.25
Evolution of Tn21-related transposons: isolation of Tn2425, which harbours IS161. J Gen Microbiol (1985) 1.24
Enterobacterial common antigen in rfb deletion mutants of Salmonella typhimurium. J Bacteriol (1976) 1.22
Genetic and immunochemical studies on Escherichia coli O14:K7:H-. Eur J Biochem (1974) 1.21
Genetic control of beta-lactamase production in Enterobacter cloacae. Rev Infect Dis (1988) 1.21
Tn21-specific structures in gram-negative bacteria from clinical isolates. Antimicrob Agents Chemother (1992) 1.20
A new function of the activated third component of complement: binding to C5, an essential step for C5 activation. Immunology (1978) 1.20
Extent of cardiac sympathetic neuronal damage is determined by the area of ischemia in patients with acute coronary syndromes. Circulation (2000) 1.20
Natural antibiotic susceptibility of Providencia stuartii, P. rettgeri, P. alcalifaciens and P. rustigianii strains. J Med Microbiol (1998) 1.19
Complement activation by the properdin system: formation of a stoichiometric. C3 cleaving complex of properdin factor B with C36. Immunochemistry (1977) 1.19
Immunochemical studies of polysaccharide surface antigens of Escherichia coli 0100:K?(B):H2. Eur J Biochem (1970) 1.19
Natural antibiotic susceptibility of Enterobacter amnigenus, Enterobacter cancerogenus, Enterobacter gergoviae and Enterobacter sakazakii strains. Clin Microbiol Infect (2002) 1.19
Impact of the ampD gene and its product on beta-lactamase production in Enterobacter cloacae. Rev Infect Dis (1988) 1.18
Body fat measurement among Singaporean Chinese, Malays and Indians: a comparative study using a four-compartment model and different two-compartment models. Br J Nutr (2001) 1.18
Intestinal and serum antibody responses in mice after oral immunization with Salmonella, Escherichia coli, and Salmonella-Escherichia coli hybrid strains. Infect Immun (1979) 1.17
Activation of Rho GTPases by Escherichia coli cytotoxic necrotizing factor 1 increases intestinal permeability in Caco-2 cells. Infect Immun (1998) 1.17
The cell-wall lipopolysaccharide of Escherichia coli K-12. Structure and acceptor site for O-antigen and other substituents. Eur J Biochem (1976) 1.16
Natural antibiotic susceptibility of Listeria species: L. grayi, L. innocua, L. ivanovii, L. monocytogenes, L. seeligeri and L. welshimeri strains. Clin Microbiol Infect (2000) 1.16
Influence of decorin on fibroblast adhesion to fibronectin. Eur J Cell Biol (1991) 1.16
Characterization of aminoglycoside 6'-N-acetyltransferases [AAC(6')] from gram-negative bacteria and Streptomyces kanamyceticus. J Antimicrob Chemother (1985) 1.14
Formation and composition of the C3 activating enzyme complex of the properdin system. Sequential assembly of its components on solid-phase trypsin-agarose. Z Immunitatsforsch Exp Klin Immunol (1975) 1.14
Reduction in mortality from upper gastrointestinal haemorrhage. Med J Aust (1983) 1.12
A family with a presumptive C-F translocation in five generations. Ann Genet (1971) 1.12
[Differentiation of Salmonella R forms by means of antibiotics ant antibacterial dyes]. Zentralbl Bakteriol Orig (1970) 1.12
[The action of ampicillin on the intestinal flora in healthy subjects]. Zentralbl Bakteriol Orig (1965) 1.11
Small plants, large plants: the importance of plant size for the physiological ecology of vascular epiphytes. J Exp Bot (2001) 1.11
Natural antibiotic susceptibility of Escherichia coli, Shigella, E. vulneris, and E. hermannii strains. Diagn Microbiol Infect Dis (1999) 1.10
Bistability of vortex core dynamics in a single perpendicularly magnetized nanodisk. Phys Rev Lett (2009) 1.10
Identification of the region of rho involved in substrate recognition by Escherichia coli cytotoxic necrotizing factor 1 (CNF1). J Biol Chem (1999) 1.08
Elimination of plasmids by new 4-quinolones. Antimicrob Agents Chemother (1985) 1.08
Pesky trachoma suspect finally caught. Br J Ophthalmol (2004) 1.07
Mathematical corrections for bacterial loss in pharmacodynamic in vitro dilution models. Antimicrob Agents Chemother (1995) 1.07
Recombinant Yersinia YopT leads to uncoupling of RhoA-effector interaction. Infect Immun (2001) 1.07
Development of resistance in the past decade in central Europe. J Antimicrob Chemother (1986) 1.07
Biomechanical model of the human knee evaluated by neuromuscular stimulation. J Biomech (1996) 1.06
[Poisoning by diphenhydramine--forensic-toxicologic interpretation of analytic results ]. Z Rechtsmed (1982) 1.06
Natural antibiotic susceptibility of strains of Serratia marcescens and the S. liquefaciens complex: S. liquefaciens sensu stricto, S. proteamaculans and S. grimesii. Int J Antimicrob Agents (2003) 1.05